Skip to content

CATALYST PHARMACEUTICALS, INC.: 10-Q filed 2016-08-09

What CATALYST PHARMACEUTICALS, INC. reported in its quarterly report filed 2016-08-09 (fiscal Q2 2016): 27 published measures, 76 facts as tagged in accession 0001193125-16-676742.

This filing

Form
10-Q (quarterly report)
Filed
2016-08-09
Fiscal period
fiscal Q2 2016
Accession
0001193125-16-676742 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CATALYST PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-3048,940,846USD
At 2015-12-3160,101,570USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-06-302,615,713USD
At 2015-12-314,625,259USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-3046,325,133USD
At 2015-12-3155,476,311USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-06-3018,717,104USD
At 2015-12-3128,235,016USD
At 2015-06-3037,221,453USD
At 2014-12-319,096,778USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-4,568,914USD91
2016-01-01 to 2016-06-30-9,955,151USD182
2015-04-01 to 2015-06-30-4,558,503USD91
2015-01-01 to 2015-06-30-9,968,762USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-01-01 to 2016-06-3088,929USD182
2015-01-01 to 2015-06-309,040USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-30-100,030,769USD
At 2015-12-31-90,075,618USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-04-01 to 2016-06-300USD91
2016-01-01 to 2016-06-300USD182
2015-04-01 to 2015-06-300USD91
2015-01-01 to 2015-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-06-30258,518USD
At 2015-12-31191,549USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-04-01 to 2016-06-30357,269USD91
2016-01-01 to 2016-06-30815,238USD182
2015-04-01 to 2015-06-30363,895USD91
2015-01-01 to 2015-06-30678,346USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-4,814,452USD91
2016-01-01 to 2016-06-30-11,051,988USD182
2015-04-01 to 2015-06-30-4,897,330USD91
2015-01-01 to 2015-06-30-9,189,245USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-06-3048,673,440USD
At 2015-12-3159,901,133USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-06-302,305,457USD
At 2015-12-313,440,603USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-06-30707,292USD
At 2015-12-311,794,127USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-04-01 to 2016-06-304,814,452USD91
2016-01-01 to 2016-06-3011,051,988USD182
2015-04-01 to 2015-06-304,897,330USD91
2015-01-01 to 2015-06-309,189,245USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-04-01 to 2016-06-302,508,897USD91
2016-01-01 to 2016-06-306,055,288USD182
2015-04-01 to 2015-06-302,577,508USD91
2015-01-01 to 2015-06-304,927,060USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-06-3082,870,649shares
At 2015-12-3182,850,619shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-06-30146,273,031USD
At 2015-12-31145,469,078USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-06-30350,554USD
At 2015-12-31261,623USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-06-3092,036USD
At 2015-12-3170,074USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-06-301,598,165USD
At 2015-12-311,646,476USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-06-30650,977USD
At 2015-12-311,504,738USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-4,568,914USD91
2016-01-01 to 2016-06-30-9,955,151USD182
2015-04-01 to 2015-06-30-4,558,503USD91
2015-01-01 to 2015-06-30-9,968,762USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-302,305,555USD91
2016-01-01 to 2016-06-304,996,700USD182
2015-04-01 to 2015-06-302,319,822USD91
2015-01-01 to 2015-06-304,262,185USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-04-01 to 2016-06-308,762USD91
2016-01-01 to 2016-06-3021,960USD182
2015-04-01 to 2015-06-308,975USD91
2015-01-01 to 2015-06-3017,123USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-04-01 to 2016-06-3092,755USD91
2016-01-01 to 2016-06-30210,698USD182
2015-04-01 to 2015-06-304,871USD91
2015-01-01 to 2015-06-3066,805USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-1,086,835USD182
2015-01-01 to 2015-06-30-497,918USD181

Inspect the source

Entity
CATALYST PHARMACEUTICALS, INC. / CIK 0001369568
Captured
2026-09-21T17:19:25.463Z
SEC response SHA-256
7cf76a511a9127dd31ed7d53955bbe348f790d8d7fd354d359e6674e7b2af9c9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001369568.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))